121 related articles for article (PubMed ID: 8613543)
1. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.
Li Y; Song YH; Rais N; Connor E; Schatz D; Muir A; Maclaren N
J Clin Invest; 1996 Feb; 97(4):910-4. PubMed ID: 8613543
[TBL] [Abstract][Full Text] [Related]
2. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.
Mayer A; Ploix C; Orgiazzi J; Desbos A; Moreira A; Vidal H; Monier JC; Bienvenu J; Fabien N
J Clin Endocrinol Metab; 2004 Sep; 89(9):4484-8. PubMed ID: 15356052
[TBL] [Abstract][Full Text] [Related]
3. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
[TBL] [Abstract][Full Text] [Related]
4. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Brown EM
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
[TBL] [Abstract][Full Text] [Related]
5. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.
Kifor O; McElduff A; LeBoff MS; Moore FD; Butters R; Gao P; Cantor TL; Kifor I; Brown EM
J Clin Endocrinol Metab; 2004 Feb; 89(2):548-56. PubMed ID: 14764760
[TBL] [Abstract][Full Text] [Related]
6. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism.
Fattorossi A; Aurbach GD; Sakaguchi K; Cama A; Marx SJ; Streeten EA; Fitzpatrick LA; Brandi ML
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4015-9. PubMed ID: 3287382
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and classification of autoimmune parathyroid disease.
Betterle C; Garelli S; Presotto F
Autoimmun Rev; 2014; 13(4-5):417-22. PubMed ID: 24424178
[TBL] [Abstract][Full Text] [Related]
8. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
9. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.
Gylling M; Kääriäinen E; Väisänen R; Kerosuo L; Solin ML; Halme L; Saari S; Halonen M; Kämpe O; Perheentupa J; Miettinen A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4602-8. PubMed ID: 14557429
[TBL] [Abstract][Full Text] [Related]
10. Is idiopathic hypoparathyroidism an autoimmune disease?
Rose NR
J Clin Invest; 1996 Feb; 97(4):899-900. PubMed ID: 8613541
[No Abstract] [Full Text] [Related]
11. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells.
Posillico JT; Wortsman J; Srikanta S; Eisenbarth GS; Mallette LE; Brown EM
J Bone Miner Res; 1986 Oct; 1(5):475-83. PubMed ID: 3332555
[TBL] [Abstract][Full Text] [Related]
12. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies.
Di Zenzo G; Calabresi V; Grosso F; Caproni M; Ruffelli M; Zambruno G
J Invest Dermatol; 2007 Apr; 127(4):864-73. PubMed ID: 17068480
[TBL] [Abstract][Full Text] [Related]
13. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism.
Goswami R; Brown EM; Kochupillai N; Gupta N; Rani R; Kifor O; Chattopadhyay N
Eur J Endocrinol; 2004 Jan; 150(1):9-18. PubMed ID: 14713274
[TBL] [Abstract][Full Text] [Related]
15. Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism.
Tomar N; Gupta N; Goswami R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3884-91. PubMed ID: 23873991
[TBL] [Abstract][Full Text] [Related]
16. Celiac disease and hypoparathyroidism: cross-reaction of endomysial antibodies with parathyroid tissue.
Kumar V; Valeski JE; Wortsman J
Clin Diagn Lab Immunol; 1996 Mar; 3(2):143-6. PubMed ID: 8991626
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O
N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283
[TBL] [Abstract][Full Text] [Related]
18. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions.
Betterle C; Caretto A; Zeviani M; Pedini B; Salviati C
Clin Exp Immunol; 1985 Nov; 62(2):353-60. PubMed ID: 3910313
[TBL] [Abstract][Full Text] [Related]
19. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
20. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
